- Patients on strong inhibitors of CYP1A2 (e.g., fluvoxamine, ciprofloxacin) as these may increase plasma concentrations of bendamustine, and decrease plasma concentrations of its metabolites. (This applies to patients who receive bendamustine for cytoreduction (optional) or lymphodepletion (required) up through 72 hours after the last dose of bendamustine)